Sesen Bio Inc. Common Stock (SESN)
About The Company
Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer.
IPO Year | Sector | Industry |
---|---|---|
2014 | Health Care | Biotechnology: Pharmaceutical Preparations |
Sesen Bio Inc. (SESN) Latest News
Company Contact & Address (SESN)
Corporate Headquarters | Phone | Website |
---|---|---|
245 FIRST STREET SUITE 1800, CAMBRIDGE, Massachusetts, 2142, United States |
+1 617 444-8550 | Official SESN Website |
SESN Key Executives
Ownership and management information.
Key Data Points*
Exchange | Not Available | Market Cap | Not Available |
---|---|---|---|
Sector | Health Care | P/E Ratio | Not Available |
Industry | Biotechnology: Pharmaceutical Preparations | Forward P/E 1 Yr. | Not Available |
1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
Today’s High/Low | Not Available | Annualized Dividend | Not Available |
Share Volume | Not Available | Ex Dividend Date | Not Available |
Average Volume | Not Available | Dividend Pay Date | Not Available |
Previous Close | Not Available | Current Yield | Not Available |
52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ SESN
Jobs & Employment at Sesen Bio Inc.
LinkedIn Company Page | https://www.linkedin.com/company/sesenbio |
---|---|
Official Career & Employment Page | Careers & Jobs at Sesen Bio Inc. (SESN) |
Related & Similar Stock Symbols
![]() GLHAUGlass Houses Acquisition Corp. Unit
|
![]() NTRSONorthern Trust Corporation Depositary Shares Each Representing …
|
![]() SSSSLSuRo Capital Corp. 6.00% Notes due 2026
|